论文部分内容阅读
目的:探讨疏血通联合低分子量肝素治疗下肢静脉血栓的临床疗效。方法:本次研究的106例下肢静脉血栓患者均为本院2013年1月-2014年6月收治,采取随机数字法将其分为观察组和对照组,每组53例,观察组实施疏血通联合低分子量肝素治疗,对照组患者只进行低分子量肝素治疗,对比两组患者的治疗效果以及凝血指标变化。结果:观察组治疗总有效率为96.27%,对照组治疗总有效率为81.13%;观察组活化部分凝血酶原时间(APPT)和凝血酶原时间(PT)明显优于对照组,两组患者的治疗总有效率和凝血指标改善情况的组间比较,差异具有统计学意义(P<0.05)。结论:疏血通联合低分子量肝素治疗下肢静脉血栓的临床疗效肯定,且有利于改善患者凝血指标。
Objective: To investigate the clinical effect of Shuxuetong combined with low molecular weight heparin on venous thrombosis of lower extremity. Methods: A total of 106 patients with venous thrombosis of the lower extremities in our study were admitted to our hospital from January 2013 to June 2014. The patients were divided into observation group and control group by random number method, with 53 cases in each group. Blood circulation combined with low molecular weight heparin treatment, the control group of patients treated with low molecular weight heparin only, compared the two groups of patients with treatment and changes in coagulation index. Results: The total effective rate was 96.27% in the observation group and 81.13% in the control group. The activation partial prothrombin time (APPT) and prothrombin time (PT) in the observation group were significantly better than those in the control group. The two groups The total effective rate and improvement of coagulation index were compared between groups, the difference was statistically significant (P <0.05). Conclusion: Shuxuetong combined with low molecular weight heparin for the treatment of lower extremity venous thrombosis certain clinical efficacy, and help to improve the coagulation index.